| 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | -282,4 k € | +75.4% | -1,1 M € | -126.9% | -505,9 k € | -59.9% | -316,3 k € | |
| EBITDA | -319,4 k € | +72.3% | -1,2 M € | -127.8% | -506,6 k € | -60.2% | -316,3 k € | |
| Operating profit | -320,8 k € | +72.2% | -1,2 M € | -128.0% | -506,8 k € | -60.2% | -316,3 k € | |
| Profit/loss | -324,6 k € | +71.9% | -1,2 M € | -127.2% | -508,9 k € | -59.9% | -318,4 k € | |
| Equity | 602,2 k € | +13.5% | 530,4 k € | +165.7% | -807,4 k € | -11151.5% | -7,2 k € | |
| Total assets | 2,2 M € | +141.7% | 926,1 k € | -32.0% | 1,4 M € | +744.9% | 161,1 k € | |
| Cash | 218,3 k € | -56.6% | 503,5 k € | -36.9% | 797,5 k € | +1065.4% | 68,4 k € | |
| Debts | 1,6 M € | +313.5% | 395,7 k € | -81.8% | 2,2 M € | +1188.7% | 168,3 k € | |
| Staff | 0 | 0 | — | — | ||||
Private limited company · Charleroi · incorporated on 10/09/2020 · 0,0 ETP
Private limited company loss-making in the latest fiscal year. Cash position declining (-56.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Genflow Biosciences is a Private limited company incorporated in 2020. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette